Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Abstract Background Glucagon-like peptide-1 (GLP-1) receptor agonists were recently approved for obesity treatment in children 1217 years by both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA)
Amylin was identified in the 1980s as a peptide co-secreted with insulin by the pancreatic beta cells, and researchers recognized early that it contributes to satiety and glucose regulation
L., Dear, J
J., Paquin, R., Harris, A., & Jezzard, P
PMC 3564852
US$ 21.67
US$ 23.04
US$ 28.30
US$ 22.25
US$ 26.08
US$ 25.35
US$ 26.00
